CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity
CARM1 is an arginine methyltransferase often overexpressed in human cancer. Here, the authors show that EZH2 inhibition suppresses growth in CARM1-expressing epithelial ovarian cancer, and examine the mechanism of how CARM1 promotes EZH2-mediated tumor suppressor gene silencing.
Guardado en:
Autores principales: | Sergey Karakashev, Hengrui Zhu, Shuai Wu, Yuhki Yokoyama, Benjamin G. Bitler, Pyoung-Hwa Park, Jeong-Heon Lee, Andrew V. Kossenkov, Krutika Satish Gaonkar, Huihuang Yan, Ronny Drapkin, Jose R. Conejo-Garcia, David W. Speicher, Tamas Ordog, Rugang Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d5feab71b5d34b35b80ea5240b6980bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SWI/SNF catalytic subunits’ switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells
por: Shuai Wu, et al.
Publicado: (2018) -
Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer
por: Jianhuang Lin, et al.
Publicado: (2021) -
Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation
por: Jie Zhou, et al.
Publicado: (2019) -
Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML
por: Julia M. Kempf, et al.
Publicado: (2021) -
Inhibitors of the Histone Methyltransferases EZH2/1 Induce a Potent Antiviral State and Suppress Infection by Diverse Viral Pathogens
por: Jesse H. Arbuckle, et al.
Publicado: (2017)